VERVE THERAPEUTICS INC's ticker is VERV and the CUSIP is 92539P101. A total of 128 filers reported holding VERVE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.34 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,219,230 | +294400.0% | 91,948 | +220.6% | 0.00% | – |
Q1 2023 | $414 | -100.0% | 28,679 | -59.3% | 0.00% | -100.0% |
Q3 2022 | $2,418,000 | -57.4% | 70,400 | -81.1% | 0.00% | -75.0% |
Q2 2022 | $5,679,000 | -77.0% | 371,671 | -9.3% | 0.00% | -73.3% |
Q2 2021 | $24,702,000 | – | 409,994 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Alphabet Inc. | 10,974,011 | $515,778,000 | 12.24% |
Casdin Capital, LLC | 3,038,167 | $142,794,000 | 3.55% |
Redmile Group, LLC | 1,869,030 | $87,844,000 | 1.53% |
Logos Global Management LP | 443,265 | $20,833,000 | 1.50% |
Novo Holdings A/S | 600,000 | $28,200,000 | 1.46% |
Cormorant Asset Management, LP | 709,224 | $32,667,000 | 1.33% |
Rock Springs Capital Management LP | 962,826 | $45,253,000 | 0.95% |
HighVista Strategies LLC | 18,782 | $883,000 | 0.58% |
RA Capital Management | 880,284 | $41,373,000 | 0.57% |
Nicholas Investment Partners, LP | 132,300 | $6,218,000 | 0.45% |